Paul E. Oberstein

机构：NYU Langone Health, New York University · ORCID：0000-0001-5918-6004

发表论文 231 篇 · 总被引 7825 次 · h-index 25

代表论文

• Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer (2025 · JAMA Oncology · 被引 27)
• Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial (2026 · Nature Medicine · 被引 7)
• Emerging Therapeutic Approaches to Pancreatic Adenocarcinoma: Advances and Future Directions (2025 · Current Treatment Options in Oncology · 被引 7)
• Daraxonrasib, a RAS(ON) multi-selective inhibitor vs chemotherapy in previously treated metastatic pancreatic adenocarcinoma (mPDAC): Primary and final analysis from the phase 3 RASolute 302 study. (2026 · Journal of Clinical Oncology · 被引 5)
• A phase 0, window of opportunity study of parasympathetic stimulation with bethanechol in localized pancreatic adenocarcinoma prior to surgery (2025 · The Oncologist · 被引 3)
• Amivantamab treatment and intra-tumoral gene expression and immune cell changes in refractory metastatic colorectal cancer (mCRC): Whole transcriptome RNA-sequencing analysis from the OrigAMI-1 study. (2025 · Journal of Clinical Oncology · 被引 3)